An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
Clinical trial NCT02343744 · COMPLETED
Trial details
- NCT number
- NCT02343744
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-19
- Primary completion
- 2015-12-04
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.